GlassScriptPhysician profile
Megan Ricard
NPI 1215438304
$7,226.10
in general payments reported to CMS, 2019-2025
13 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,625 · 2022: $2,944 · 2023: $189 · 2024: $381 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,965.88 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Infinion 16 |
| Collegium Pharmaceutical, INC. | $251.61 | 2023-2025 | Belbuca, Xtampza |
| Janssen Pharmaceuticals, INC | $244.53 | 2025 | Spravato |
| Abbvie INC. | $224.42 | 2025 | |
| Spr Therapeutics, INC | $205.11 | 2021-2025 | Sprint Pns System |
| Painteq LLC | $97.67 | 2021 | |
| Si-Bone, INC. | $85.41 | 2022 | |
| Saluda Medical Americas, INC. | $45.96 | 2025 | Evoke |
| Curonix LLC | $24.70 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $23.60 | 2024 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $20.38 | 2025 | |
| Grt US Holding, INC. | $18.55 | 2021 | |
| Abbott Laboratories | $18.28 | 2025 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Ricard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.